Chronic obstructive pulmonary disease (COPD) affects 16 million Americans and is projected to cost our nation $49 billion in care in 2020. Despite this, investment in research to combat COPD remains stagnant. Research!America will be hosting a congressional briefing, "From Discovery to Delivery: Research at Work - COPD," November 15, 2017, 12:30-1:30 in the U.S. Capitol Building, S-115.
COPD is a term used to describe a group of lung diseases, including emphysema and chronic bronchitis, characterized by shortness of breath and a chronic cough. Research on COPD, like all medical research, spans a continuum from basic science to care delivery. COPD is currently the third leading cause of death in the U.S. Current treatments consist of symptom management, and do not address the source of the condition.
Featured panelists include Gary Gibbons, M.D., director, National Heart, Lung, and Blood Institute; David Mannino, M.D., FCCP, FERS , U.S. respiratory medical expert, GlaxoSmithKline; Grace Anne Dorney Koppel, JD, M.A., president, Dorney-Koppel Foundation, living with COPD; Jerry Krishnan, M.D., Ph.D., associate vice chancellor for population health sciences, professor of medicine and public health, University of Illinois at Chicago. The discussion will be moderated by Lisa Simpson, MB, BCh, MPH, FAAP, president and CEO, AcademyHealth.
Following the panel discussion, the “Walk in My Shoes Challenge” COPD Interactive Experience will simulate what it is like to complete daily activities for an individual living with COPD. For more information, click here.